Ovarian Cancer IMPACT Act Has Been Introduced

New legislation aims to expand genetic testing coverage and renew federal cancer education programs.

Updated on Sept. 29, 2026 in Cancer

Bold flat-color editorial illustration of a laboratory centrifuge, representing medical genetic testing policy. — Lawmakers have introduced the Ovarian Cancer IMPACT Act, a new bill aimed at mandating insurance coverage for genetic cancer screenings and renewing federal education programs. AI Illustration. Upload story photo >

Live Poll

Should insurance companies be legally required to cover more preventative genetic testing for cancer risks?

Lawmakers have introduced the Ovarian Cancer IMPACT Act, a bill designed to mandate private insurance coverage for genetic cancer screenings. The initiative also seeks to reauthorize Johanna's Law, a long-standing federal education program.

Why it matters

The bill aims to improve early detection and prevention of gynecologic cancers while addressing critical disparities in access to specialty care and testing. By funding federal outreach, the act seeks to ensure more patients understand their personal risk factors.

The legislation reauthorizes Johanna's Law, a 20-year-old CDC initiative focused on gynecologic cancer education. It mandates that private insurance plans cover genetic testing for patients identified with hereditary risk factors.

The players

Elissa Slotkin

She is a U.S. Senator representing Michigan who has been a proponent of health legislation.

Katie Britt

She is a U.S. Senator representing Alabama involved in the legislative push.

Centers for Disease Control and Prevention

This federal agency manages public health programs, including the existing education initiative known as Johanna's Law.

The details

The Ovarian Cancer IMPACT Act expands federal education and outreach regarding the risks associated with gynecologic cancers. By requiring insurers to cover genetic screenings, the bill intends to bridge gaps for patients facing hereditary health risks.

In 2011, Judith Slotkin passed away due to ovarian cancer.
Lawmakers officially introduced the Ovarian Cancer IMPACT Act in 2026.

The Big Picture

The introduction of this act extends the legacy of Johanna's Law, a 20-year-old federal program focused on gynecologic cancer awareness. It updates the nation's strategy by integrating mandatory genetic screening coverage alongside existing education efforts.

If passed, the legislation will require private insurance plans to cover genetic testing, potentially removing a major financial barrier for at-risk patients. This change could allow more women to identify hereditary predispositions to cancer earlier in their treatment journey.

The takeaway

The proposed act underscores a shift toward prioritizing preventative genetic medicine in federal healthcare policy. Patients should monitor the status of this legislation as it may eventually change the cost-sharing structure for hereditary cancer screenings.